Researchers test potential of artificial blood vessels

04/25/2013 | HealthDay News

Artificial blood vessels made using a biodegradable mesh tube as a scaffold for aorta cells have shown positive results in an animal study and a clinical trial has begun, according to findings presented online through the American Heart Association. The process for the new blood vessel to develop and the mesh structure to dissolve takes two months. Tests on primates showed the synthetic blood vessels can endure frequent needle sticks. A clinical trial in Europe is underway, and a study in the U.S. has been granted FDA authorization.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC